T1	Intervention 0 10	Ipilimumab
T2	Intervention 142 219	fully human, monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4
T3	Intervention 966 1020	0.3, 3, or 10 mg/kg ipilimumab in four phase II trials
